| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
From the Department of Clinical Pharmacology, GKT Division of Cardiovascular Medicine, St Thomas Hospital, London, United Kingdom.
Correspondence to J.M. Ritter, Department of Clinical Pharmacology, St Thomas Hospital, Lambeth Palace Road, London, SE1 7EH, UK. E-mail james.ritter{at}kcl.ac.uk
Objective To investigate the possible involvement of inward rectifying K+ channels (KIR) in the response of human resistance vessels to bradykinin in vivo.
Methods and Results Drugs were administered via the brachial artery in healthy male volunteers and forearm blood flow was measured by venous occlusion plethysmography. Inhibition of KIR by barium chloride (4 µmol min1) alone or with additional inhibition of Na+/K+ ATPase (ouabain 2.7 µmol min1) reduced responses to bradykinin (30 pmol min1), by 26±8.3% and 36±7.2%, respectively (each P<0 0.05). Barium with ouabain plus inhibitors of prostaglandin (PG) and nitric oxide synthesis inhibited but did not abolish responses to bradykinin (51±2.8% inhibition; P<0.01); norepinephrine (240 pmol min1) caused similar reduction of baseline blood flow, as did this combination of inhibitors, but did not significantly inhibit the response to bradykinin. Barium plus ouabain did not significantly reduce responses to acetylcholine or albuterol.
Conclusion A component of the vasodilator response to bradykinin in human forearm vasculature is mediated by KIR.
The possible involvement of inward-rectifying K+ channels (KIR) in the action of bradykinin was investigated by administering drugs via the brachial artery in healthy men. Barium selectively inhibited the forearm blood flow response to bradykinin, indicating that a component of this response is mediated by KIR.
Key Words: bradykinin barium forearm vasculature inward-rectifying potassium channels hyperpolarizing factor
This article has been cited by other articles:
![]() |
I. C. Villar, C. M. Panayiotou, A. Sheraz, M. Madhani, R. S. Scotland, M. Nobles, B. Kemp-Harper, A. Ahluwalia, and A. J. Hobbs Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor Cardiovasc Res, June 1, 2007; 74(3): 515 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Jackson Silent Inward Rectifier K+ Channels in Hypercholesterolemia Circ. Res., April 28, 2006; 98(8): 982 - 984. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |